Supplementary Table 3 from The Metabolomic Signature of Malignant Glioma Reflects Accelerated Anabolic Metabolism
Prakash Chinnaiyan, Robert J. Gillies(University of Calgary), Soumen Kahali(Moffitt Cancer Center), Antony Prabhu, Elizabeth Kensicki(Metabolon (United States)), Bhaswati Sarcar(Moffitt Cancer Center), Steven A. Eschrich(Moffitt Cancer Center), Peter Forsyth(Moffitt Cancer Center), Xiaotao Qu(The Affiliated Yongchuan Hospital of Chongqing Medical University), Gregory Bloom(Moffitt Cancer Center)
Cited by 0
Related Papers
Nivolumab in metastatic urothelial carcinoma after platinum therapy (CheckMate 275): a multicentre, single-arm, phase 2 trial
|The Lancet Oncology|2017|1.8k
Stereotactic Ablative Radiotherapy for the Comprehensive Treatment of Oligometastatic Cancers: Long-Term Results of the SABR-COMET Phase II Randomized Trial
|Journal of Clinical Oncology|2020|1.3k
Common Genetic Variation In Cellular Transport Genes and Epithelial Ovarian Cancer (EOC) Risk
|PLoS ONE|2015|906
Abbreviated Course of Radiation Therapy in Older Patients With Glioblastoma Multiforme: A Prospective Randomized Clinical Trial
|Journal of Clinical Oncology|2004|888
Causes and Consequences of Increased Glucose Metabolism of Cancers
|Journal of Nuclear Medicine|2008|638